EF
BIO icon

Empirical Finance’s Bio-Rad Laboratories Class A BIO Stock Holding History

Empirical Finance’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-501
Closed -$240K – 516
2023
Q1 		$240K Buy
+501
New +$235K 0.02% 477
2022
Q2 		– Sell
-358
Closed -$202K – 469
2022
Q1 		$202K Buy
358
+45
+14% +$27.1K 0.02% 476
2021
Q4 		$236K Buy
+313
New +$234K 0.03% 437

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Empirical Finance's BIO Position: Q2 2023 in Review

Empirical Finance sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 501 shares — an estimated $240K sold.

Empirical Finance first reported a position in BIO in Q4 2021 and held it in 3 quarters. The position peaked at $240K in Q1 2023. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Empirical Finance reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Empirical Finance sold 501 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $240K.
  • Empirical Finance first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 3 quarters.
  • Empirical Finance's Bio-Rad Laboratories Class A position peaked at $240K in Q1 2023.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Empirical Finance's 13F filing for Q2 2023, filed 27 Jul 2023.